Work

Imipramine versus escitalopram in generalized anxiety disorder

Year: 2026
Type: article
Study design: Observational Study
Abstract: Generalized anxiety disorder (GAD) is a common, chronic condition, and real-world comparative data on imipramine and escitalopram are limited. Therefore, it is of interest to compare their effectiveness and safety in outpatients with newly diagnosed GAD over 24 weeks. In this prospective observational study at Gandhi Medical College and Hamidia Hospital, Bhopal, 100 patients received imipramine (n=50) or escitalopram (n=50) at the treating physician's discretion. Anxiety was assessed with the Hamilton Anxiety Rating Scale (HAM-A) at baseline and at weeks 4, 12 and 24, and adverse drug reactions were recorded. Mean HAM-A score fell from 35.05 to 9.42 (73.1%) with imipramine and from 36.08 to 8.95 (75.2%) with escitalopram. Drowsiness was significantly more frequent with imipramine (36% vs 2%; P<0.001). Thus, both drugs produced comparable, substantial reductions in anxiety, with better tolerability for escitalopram; randomized trials are warranted.
Author: Yogesh Jain
Language: English
Field: Psychology
Open Access status: hybrid
OpenAlex ID: W7225140176
FWCI:
Cites: 23
Cited by:
Related to: 10